| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
BIOA
BioAge Labs, Inc.
|
Jun 16, 2026 | HOLD |
Strong Buy
+145.1% avg upside
9 analysts
|
$23.00
15.06% Upside
|
· |
|
MIRM
Mirum Pharmaceuticals
|
Jun 15, 2026 | BUY |
Strong Buy
+10.1% avg upside
21 analysts
|
$150.00
47.02% Upside
|
+6.1% |
|
RYTM
Rhythm Pharmaceuticals
|
Jun 14, 2026 | BUY |
Strong Buy
+26.0% avg upside
19 analysts
|
$136.00
41.99% Upside
|
+6.8% |
|
ALNY
Alnylam Pharma
|
Jun 12, 2026 | HOLD |
Strong Buy
+22.4% avg upside
51 analysts
|
$370.00
30.89% Upside
|
+0.0% |
|
IONS
Ionis Pharmaceuticals
|
Jun 12, 2026 | BUY |
Strong Buy
+13.0% avg upside
43 analysts
|
$130.00
74.86% Upside
|
+0.0% |
|
VIR
Vir Biotechnology
|
Jun 11, 2026 | BUY |
Strong Buy
+182.3% avg upside
16 analysts
|
$27.00
190.40% Upside
|
+1.1% |
|
SLN
Silence Therapeutics
|
Jun 11, 2026 | BUY |
Strong Buy
+380.0% avg upside
9 analysts
|
$25.00
269.74% Upside
|
· |
|
GUTS
Fractyl Health, Inc.
|
Jun 04, 2026 | HOLD |
Strong Buy
+455.3% avg upside
6 analysts
|
$2.00
135.29% Upside
|
-8.7% |
|
CABA
Cabaletta Bio
|
Jun 03, 2026 | BUY |
Strong Buy
+388.8% avg upside
16 analysts
|
$13.00
357.72% Upside
|
· |
|
KYTX
Kyverna Therapeutics, Inc.
|
Jun 03, 2026 | BUY |
Strong Buy
+239.9% avg upside
7 analysts
|
$33.00
310.51% Upside
|
+2.8% |
|
TNYA
Tenaya Therapeutics
|
Jun 03, 2026 | BUY |
Strong Buy
+1328.2% avg upside
11 analysts
|
$2.00
181.01% Upside
|
· |
|
DYN
Dyne Therapeutics
|
Jun 03, 2026 | BUY |
Strong Buy
+98.3% avg upside
29 analysts
|
$47.00
144.88% Upside
|
+4.1% |
|
ARWR
Arrowhead Pharmaceuticals
|
May 27, 2026 | BUY |
Strong Buy
-18.4% avg upside
26 analysts
|
$100.00
23.42% Upside
|
-5.7% |
|
AARD
Aardvark Therapeutics, Inc.
|
May 15, 2026 | SELL |
Buy
+399.2% avg upside
12 analysts
|
$3.00
21.41% Downside
|
-0.0% |
|
ZNTL
Zentalis Pharmaceuticals
|
May 13, 2026 | HOLD |
Buy
+300.1% avg upside
16 analysts
|
$4.00
10.53% Upside
|
-16.4% |
|
VKTX
Viking Therapeutics
|
Apr 30, 2026 | BUY |
Strong Buy
+141.0% avg upside
30 analysts
|
$95.00
213.60% Upside
|
-4.9% |
|
RCKT
Rocket Pharmaceuticals
|
Mar 27, 2026 | HOLD |
Buy
+418.9% avg upside
29 analysts
|
$5.00
58.32% Upside
|
-21.5% |
|
SRPT
Sarepta Therapeutics
|
Mar 26, 2026 | HOLD |
Buy
+251.8% avg upside
49 analysts
|
$25.00
47.31% Upside
|
-27.4% |
|
IOBTQ
IO Biotech
|
Jan 08, 2026 | SELL |
Buy
+78483.3% avg upside
6 analysts
|
$0.36
5899.98% Upside
|
· |
|
XLO
Xilio Therapeutics
|
Mar 11, 2025 | BUY |
Strong Buy
+96.6% avg upside
7 analysts
|
$5.00
42.76% Downside
|
-31.9% |
|
FATE
Fate Therapeutics
|
Mar 06, 2025 | HOLD |
Buy
+512.6% avg upside
31 analysts
|
$5.00
155.09% Upside
|
+27.9% |
|
HLIT
Harmonic
|
Feb 11, 2025 | HOLD |
Buy
-12.4% avg upside
14 analysts
|
$5.00
66.32% Downside
|
+6.3% |
|
KLRS
Kalaris Therapeutics
|
Aug 13, 2024 | SELL |
Buy
+177.8% avg upside
13 analysts
|
$0.50
89.09% Downside
|
+86.7% |
|
KPTI
Karyopharm Therapeutics
|
Dec 15, 2023 | HOLD |
Strong Buy
+139.5% avg upside
18 analysts
|
— | -9.6% |
|
SNTI
Senti Biosciences
|
Dec 15, 2023 | HOLD |
Strong Buy
+820.3% avg upside
7 analysts
|
— | +45.8% |
|
LKFT
Lakefront Biotherapeutics
|
Aug 22, 2023 | HOLD |
Hold
+272.1% avg upside
24 analysts
|
$40.00
40.99% Upside
|
· |
|
IOVA
Iovance Biotherapeutics
|
May 22, 2023 | BUY |
Strong Buy
+223.6% avg upside
24 analysts
|
$23.00
485.23% Upside
|
+29.3% |
|
TSHA
Taysha Gene Therapies
|
Jan 27, 2023 | HOLD |
Strong Buy
+108.8% avg upside
21 analysts
|
$3.00
51.59% Downside
|
-15.9% |
|
TECX
Tectonic Therapeutic
|
Jan 05, 2022 | HOLD |
Strong Buy
+88.0% avg upside
24 analysts
|
$3.00
89.95% Downside
|
-62.0% |
|
CHRS
Coherus Biosciences
|
Mar 12, 2021 | HOLD |
Buy
+798.0% avg upside
18 analysts
|
— | -24.1% |
|
BMRN
BioMarin Pharmaceutical
|
Mar 12, 2021 | HOLD |
Strong Buy
+71.7% avg upside
52 analysts
|
— | -1.0% |
|
IDYA
IDEAYA Biosciences
|
Mar 12, 2021 | HOLD |
Strong Buy
+55.3% avg upside
29 analysts
|
— | -44.2% |
|
NGNE
Neurogene
|
Mar 12, 2021 | HOLD |
Buy
+58.4% avg upside
23 analysts
|
— | -82.2% |
|
RARE
Ultragenyx Pharmaceutical
|
Mar 12, 2021 | HOLD |
Strong Buy
+144.1% avg upside
36 analysts
|
— | -48.5% |
|
ARGX
Argenx Se
|
Mar 04, 2021 | BUY |
Strong Buy
-16.4% avg upside
46 analysts
|
$340.00
61.99% Downside
|
-8.6% |
|
ARCT
Arcturus Therapeutics
|
Mar 01, 2021 | HOLD |
Buy
+298.1% avg upside
35 analysts
|
$60.00
715.26% Upside
|
-59.6% |
|
NRIX
Nurix Therapeutics
|
Feb 16, 2021 | BUY |
Strong Buy
+79.9% avg upside
26 analysts
|
— | -59.7% |
|
SNDX
Syndax Pharmaceuticals
|
Jan 29, 2021 | BUY |
Strong Buy
+87.3% avg upside
27 analysts
|
$37.00
94.30% Upside
|
-22.2% |
|
CYPH
Cypherpunk Technologies
|
Jan 29, 2021 | BUY |
Buy
+1073.7% avg upside
9 analysts
|
$5.00
556.07% Upside
|
· |
|
ORIC
Oric Pharmaceuticals
|
Aug 12, 2020 | BUY |
Strong Buy
+176.0% avg upside
19 analysts
|
$45.00
421.36% Upside
|
-25.1% |
|
GNCAQ
Genocea Biosciences
|
Jul 30, 2020 | BUY |
Strong Buy
+573999900.0% avg upside
10 analysts
|
$8.00
799999899.91% Upside
|
· |
|
TARA
Protara Therapeutics
|
Mar 28, 2019 | HOLD |
Strong Buy
+1134.8% avg upside
21 analysts
|
$40.00
882.82% Upside
|
+9.3% |
|
SRL
Scully Royalty
|
Oct 03, 2017 | BUY |
Strong Buy
3 analysts
|
— | · |
|
GILD
Gilead Sciences
|
May 18, 2010 | BUY |
Strong Buy
-5.6% avg upside
66 analysts
|
$27.50
77.98% Downside
|
+5.4% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.